Mannkind (MNKD) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.15% |
| Dec 31, 2025 | 13.46% |
| Sep 30, 2025 | -3.06% |
| Jun 30, 2025 | 27.97% |
| Mar 31, 2025 | 39.39% |
| Dec 31, 2024 | 32.91% |
| Sep 30, 2024 | -78.93% |
| Jun 30, 2024 | -72.15% |
| Mar 31, 2024 | -81.01% |
| Dec 31, 2023 | -72.73% |
| Sep 30, 2023 | 14.56% |
| Jun 30, 2023 | 6.36% |
| Mar 31, 2023 | -2.30% |
| Dec 31, 2022 | 16.30% |
| Sep 30, 2022 | -18.73% |
| Jun 30, 2022 | 5.12% |
| Mar 31, 2022 | 41.34% |
| Dec 31, 2021 | -203.91% |
| Sep 30, 2021 | -163.71% |
| Jun 30, 2021 | -155.71% |
| Mar 31, 2021 | -612.24% |
| Dec 31, 2020 | -34.58% |
| Sep 30, 2020 | -5.31% |
| Jun 30, 2020 | -378.30% |
| Mar 31, 2020 | 34.45% |
| Dec 31, 2019 | 30.38% |
| Sep 30, 2019 | -356.19% |
| Jun 30, 2019 | 50.26% |
| Mar 31, 2019 | -117.73% |
| Dec 31, 2018 | -48.25% |
| Sep 30, 2018 | -9.73% |
| Jun 30, 2018 | 38.45% |
| Mar 31, 2018 | 43.24% |
| Dec 31, 2017 | -111.20% |
| Sep 30, 2017 | 71.85% |
| Jun 30, 2017 | 31.93% |
| Mar 31, 2017 | -73.50% |
| Dec 31, 2016 | 61.24% |
| Sep 30, 2016 | -7.90% |
| Jun 30, 2016 | 40.54% |
| Mar 31, 2016 | 77.12% |
| Dec 31, 2015 | 51.11% |
| Sep 30, 2015 | 80.91% |
| Jun 30, 2015 | -160.07% |
| Mar 31, 2015 | -237.94% |
| Dec 31, 2014 | -70.70% |
| Sep 30, 2014 | -83.86% |
| Jun 30, 2014 | -44.46% |
| Mar 31, 2014 | -27.69% |
| Dec 31, 2013 | -14.47% |
| Sep 30, 2013 | -4,335.13% |
| Jun 30, 2013 | 10.82% |
| Mar 31, 2013 | 50.61% |
| Dec 31, 2012 | -1,834.92% |
| Sep 30, 2012 | 90.92% |
| Jun 30, 2012 | -26.60% |
| Mar 31, 2012 | -20.88% |
| Dec 31, 2011 | 95.46% |
| Sep 30, 2011 | 76.21% |
| Jun 30, 2011 | 10.90% |